Re: Human papillomavirus in oral exfoliated cells and risk of head and neck cancer.
Philip E
PE
Castle
D014408:Biomarkers, Tumor / Q000032:analysis; D002294:Carcinoma, Squamous Cell / Q000821:virology; D016022:Case-Control Studies; D002584:Cervix Uteri / Q000821:virology; D004279:DNA, Viral / Q000302:isolation & purification; D005260:Female; D006258:Head and Neck Neoplasms / Q000517:prevention & control / Q000821:virology*; D006801:Humans; D009055:Mouth / Q000821:virology*; D016017:Odds Ratio; D009959:Oropharyngeal Neoplasms / Q000821:virology; D027383:Papillomaviridae / Q000235:genetics / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000150:complications / Q000517:prevention & control; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D014067:Tonsillar Neoplasms / Q000821:virology; D014412:Tumor Virus Infections / Q000150:complications / Q000517:prevention & control; D002583:Uterine Cervical Neoplasms / Q000821:virology; D014765:Viral Vaccines / Q000627:therapeutic use
D014408:Biomarkers, Tumor; D004279:DNA, Viral; D014765:Viral Vaccines